LifeSci Partners
Leading global life sciences advisory firm. Investor relations, investment banking, strategy, communications, executive search, and venture capital for biotech, pharma, and medtech companies from inception to maturity.
“This is exactly the output I want. I'd probably make five minutes of edits and then give it to our managing director.”
Associate, LifeSci Capital
Challenge
Every initiation-of-coverage report began with manual extraction from trial data, corporate decks, and peer-reviewed literature. Generic AI tools struggled with specialized biotech content, verifying information was slow, and each client-facing report introduced compliance risk.
Solution
yAI engineers embedded with the team to configure life sciences templates against the firm's report structures. The platform synthesizes roughly 10,000 pages per report, links every claim to its source, and flags gaps for associate review.
Results
Drug analyses that previously took hours now complete in one to two minutes. Expert call notes are delivered the same day the call is held, with every claim pre-cited to its source passage and auditable on demand.
Adoption
yAI is in active use across the firm's equity research and investment banking teams. Associates run it on expert call notes, ongoing coverage, and the research workflows that support both teams.